It has been observed that healthy individuals actually harbor anti-HER2 CD4+ Th1 cells that secrete IFN-γ and TNF-α, and in individuals with HER2+ BC, this immune response is diminished (119). The gene discussed is ERBB2; the disease is breast cancer.